Loading data for UTRS — first visit, this takes a few seconds.
Minerva Surgical Inc. (UTRS)
OTC Markets OTCPK: UTRS
· Real-Time Price · USD
0.00
n/a (n/a)
At close: Aug 27, 2026, 8:00 PM
The price, the headline numbers and the latest news, in one place.
Minerva Surgical Inc. (UTRS) Stock Price, Analysis & Data
No data available
| Bid | n/a |
| Market Cap | 887 |
| Revenue (ttm) | 51.69M |
| Net Income (ttm) | -33.45M |
| 150.60 | |
| -0.76 | |
| n/a | |
| 0 | |
| P/B (ttm) | n/a |
| P/S (ttm) | n/a |
| Earnings Date | n/a |
| Ask | n/a |
| Volume | 500 |
| Avg. Volume (20D) | 15 |
| Open | n/a |
| Previous Close | n/a |
| Day's Range | n/a - n/a |
| 52-Week Range | n/a - n/a |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About UTRS
Minerva Surgical, Inc. provides a suite of devices to treat the root causes of abnormal uterine bleeding in the United States. The company provides Minerva Endometrial Ablation System, a technology that uses three methods of tissue ablation; Symphion System that is designed for fluid management, direct intrauterine pressure monitoring, and bladeless resection work; and Genesys HTA, an endometrial ablation device for the treatment of a wider range...
Industry Medical Devices
Sector Healthcare
IPO Date Oct 22, 2021
Employees 174
Stock Exchange OTC Markets OTCPK
Ticker Symbol UTRS
Website https://minervasurgical.com
Financial Performance
In 2022, Minerva Surgical's revenue was 50.29M, a decrease of -3.47% compared to the previous year's 52.1M. Earnings were -34.11M, an increase of 58.93%.
Financial StatementsEarnings Surprise
Minerva Surgical has released their quarterly earnings on Nov 13, 2023:
- Revenue of n/a misses estimates by $0, with NaN% YoY growth.
- EPS of -0.81 exceeds estimates by 0.19, with 89.88% YoY growth.